Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment. 1996

R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
Department of Pneumology, Ciutat Sanitaria Universitaria Vall d'Hebron,Barcelona, Spain.

OBJECTIVE A group of patients with pulmonary tuberculosis (PT) who received and correctly completed antituberculous therapy were studied to determine the incidence and significance of positive acid-fast bacilli (AFB) in sputum smears at the end of this treatment. METHODS Retrospective chart review of persons with bacteriologically proved PT. METHODS Of 1,052 patients diagnosed as having PT between 1988 and 1992, 453 who fulfilled the following criteria were included in the study: (1) diagnosis established by positive AFB and positive culture in sputum smears; (2) no previous antituberculous treatment had been received; (3) HIV serologic test results were negative; (4) treatment was correctly completed; (5) they were followed up throughout the period of treatment; and (6) expectoration was still present at the end of treatment and at least two spontaneous sputum samples could be obtained. RESULTS Positive AFB of sputum smears were found at the end of treatment in 10 (2.2%) of the 453 patients studied. Five patients had only one positive smear, and the other five had more than one. Of these ten cases, sputum culture was negative in eight, which were considered to be unviable bacilli, and positive for nontuberculous mycobacteria in two. Clinical symptoms or worsening on chest radiograph were observed only in one patient with unviable bacilli, but they were caused by a concomitant nonspecific respiratory tract infection. CONCLUSIONS Positive AFB smear results at the end of completed treatment regimens analyzed in this study have occurred because of unviable bacilli and nontuberculous mycobacteria colonization. The presence of more than one positive smear seems not to increase the probability of treatment failure and is more frequently due to nontuberculous mycobacteria. Results of culture can thus be awaited without the need to prolong or modify antituberculous therapy.

UI MeSH Term Description Entries
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013183 Sputum Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus. Sputum, Induced,Induced Sputum,Induced Sputums,Sputums,Sputums, Induced
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises
D017211 Treatment Failure A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series. Failure, Treatment,Failures, Treatment,Treatment Failures

Related Publications

R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
February 1986, Journal of the Indian Medical Association,
R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
February 1984, The American review of respiratory disease,
R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
September 1999, Chest,
R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
September 1966, Tubercle,
R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
January 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
September 1993, Journal of clinical microbiology,
R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
January 1992, The Indian journal of chest diseases & allied sciences,
R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
September 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
July 1909, The Hospital,
R Vidal, and N Martin-Casabona, and A Juan, and T Falgueras, and M Miravitlles
December 2007, Journal of medical microbiology,
Copied contents to your clipboard!